Literature DB >> 1682491

The gold standard in rheumatoid arthritis.

J T Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682491      PMCID: PMC1293405          DOI: 10.1177/014107689108400902

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  12 in total

1.  Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis.

Authors:  E B HAMILTON; J T SCOTT
Journal:  Arthritis Rheum       Date:  1962-10

2.  Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year.

Authors:  A FREEDMAN; V L STEINBERG
Journal:  Ann Rheum Dis       Date:  1960-09       Impact factor: 19.103

3.  Treatment of lupus erythematosus with mepacrine.

Authors:  F PAGE
Journal:  Lancet       Date:  1951-10-27       Impact factor: 79.321

4.  Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.

Authors:  A Palmer; D Taube; K Welsh; M Bewick; P Gjorstrup; M Thick
Journal:  Lancet       Date:  1989-01-07       Impact factor: 79.321

5.  The early history of antirheumatic drugs.

Authors:  G P Rodnan; T G Benedek
Journal:  Arthritis Rheum       Date:  1970 Mar-Apr

6.  Antimalarial treatment of rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Med Clin North Am       Date:  1968-05       Impact factor: 5.456

7.  Screening for hydroxychloroquine retinal toxicity: is it necessary?

Authors:  C D Morsman; S J Livesey; I M Richards; J D Jessop; P V Mills
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

8.  Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.

Authors:  C Bombardier; J Ware; I J Russell; M Larson; A Chalmers; J L Read
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

9.  Sulphasalazine and regression of rheumatoid nodules.

Authors:  H J Englert; G R Hughes; M J Walport
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

10.  Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.

Authors:  H A Capell; M Marabani; R Madhok; H Torley; J A Hunter
Journal:  Q J Med       Date:  1990-04
View more
  1 in total

Review 1.  Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors:  C P Rains; S Noble; D Faulds
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.